Duquesne Family Office’s Moderna MRNA Stock Holding History

Duquesne Family Office’s Portfolio MRNA Stock Details MRNA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$3.4M	Hold
2022 Q4	$3.98M	Hold
2022 Q3	$2.62M	Sell
2022 Q2	$29.7M	Buy
2021 Q4	–	Sell
2021 Q3	$33.1M	Sell
2021 Q2	$52.3M	Buy